Form 8-K - Current report:
SEC Accession No. 0001193125-24-219692
Filing Date
2024-09-16
Accepted
2024-09-16 17:12:00
Documents
13
Period of Report
2024-09-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d891498d8k.htm   iXBRL 8-K 108921
  Complete submission text file 0001193125-24-219692.txt   246843

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA augx-20240916.xsd EX-101.SCH 2841
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE augx-20240916_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE augx-20240916_pre.xml EX-101.PRE 11701
15 EXTRACTED XBRL INSTANCE DOCUMENT d891498d8k_htm.xml XML 4062
Mailing Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISCO CA 94104
Business Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISCO CA 94104 561-989-2208
Augmedix, Inc. (Filer) CIK: 0001769804 (see all company filings)

EIN.: 833299164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40890 | Film No.: 241301876
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)